Abstract
Stent length and diameter are thought to contribute to adverse outcomes following percutaneous coronary intervention (PCI) and diameter <3.0 mm is currently included in the ACC dual-antiplatelet therapy risk calculator. Stent characteristics associated with repeat revascularization are not well described for 3rd generation drug-eluting stents (DES).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the Society for Cardiovascular Angiography & Interventions
Paper Title
Journal
Date
